Shared on 17 Nov 25
Fair value Increased 0.045%RJF: Share Repurchases And Deal Pipeline Will Drive Upside Into 2026
Analysts have modestly increased their price target for Raymond James Financial to $184.50. This slight upward revision is supported by recent positive quarterly results and ongoing strength across the company's business segments.
Shared on 02 Nov 25
Fair value Increased 2.60%Analysts have raised their price target for Raymond James Financial from $179.75 to $184.42, citing improved revenue growth and profit margin expectations following recent quarterly performance and positive business momentum. Analyst Commentary Recent street research on Raymond James Financial reflects a mix of optimism and caution among analysts, with several price target adjustments following the latest quarterly results.
Shared on 18 Oct 25
Fair value Increased 2.23%Raymond James Financial's analyst price target has been raised from $175.83 to $179.75, as analysts cite improved market sentiment, resilient trading activity, and stronger asset flows that support the company's outlook. Analyst Commentary Recent analyst updates on Raymond James Financial present a nuanced outlook, highlighting both areas of strength and potential challenges for the company.
Shared on 04 Oct 25
Fair value Increased 1.48%Raymond James Financial's analyst price target has edged higher from $173.27 to $175.83. Analysts cite disciplined advisor recruitment and higher assets under management, balanced against a slower growth outlook and elevated valuations.
Shared on 30 Apr 25
Fair value Decreased 6.81%AnalystConsensusTarget has decreased revenue growth from 6.2% to 5.5%.
Shared on 23 Apr 25
Fair value Increased 2.70%AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.
Shared on 16 Apr 25
Fair value Decreased 3.71%AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.
Shared on 02 Apr 25
Fair value Increased 4.08%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 0.98%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Increased 0.64%AnalystConsensusTarget has decreased revenue growth from 8.6% to 7.4%.

